Last Updated : Friday, February 21, 2020 20:55:47

USFDA inspection @ AUROBINDO PHARMA’s Unit IV continues …

HYDERABAD | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Hyderabad headquartered Aurobindo Pharma Ltd said of the USFDA inspection still open and under review of the company’s Unit IV, as per the communication received from the US Food and Drugs Administration, as per the previous communication, the Establishment Inspection Report was issued to the facility, with Voluntary Action Initiated status activated by US Food & Drug Regulators.

For LONG READ, please click / log on / visit :-

In case, if a reader wishes to VERIFY the above narrated news-report, please CLICK here.


FacebookLinkedinTwitterYouTube, Blogspot, Telegram, Instagram 

You can also access and/or read the above narrated news-report on our : BLOG and/or WEBSITE.


Do NOT follow this link or you will be banned from the site!